BeStock  

Progyny PGNY

US equityMarket cap rank #2515Healthcare Plans
$35.71 +$0.26 (+0.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $35.14 -1.60%
Open$35.52
Prev close$35.45
Day range$35.50 – $36.08
Volume1.11M
Market cap$2.63B
P/E (TTM)32.8
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$341.25M+8.9% YoY
Operating profit$35.18M+63.4% YoY
Net profit$26.25M+89.4% YoY
Diluted EPS$0.32+113.3% YoY
Free cash flow$47.24M+2.7% YoY
Operating cash flow$56.61M

Revenue, last 8 quarters

$298.4MDec '24$324.0MMar '25$332.9MJun '25$313.3MSep '25$318.4MDec '25$328.5MMar '26$350.5MJun '26$341.3MSep '26

Net profit, last 8 quarters

$10.5MDec '24$15.1MMar '25$17.1MJun '25$13.9MSep '25$12.5MDec '25$24.2MMar '26$28.1MJun '26$26.3MSep '26

Diluted EPS by quarter

0.12Dec '240.17Mar '250.19Jun '250.15Sep '250.14Dec '250.29Mar '260.34Jun '260.32Sep '26

Free cash flow by quarter

$50.3MDec '24$47.0MMar '25$50.2MJun '25$46.0MSep '25$48.6MDec '25$39.6MMar '26$44.2MJun '26$47.2MSep '26

Annual revenue

$344.9MFY20$500.6MFY21$786.9MFY22$1.1BFY23$1.2BFY24$1.3BFY25

Profitability & balance sheet

Gross margin24.9%
Operating margin9.4%
Net margin6.8%
Return on equity18.7%
Return on assets12.4%
Return on invested capital17.0%
Current ratio1.93
Liabilities / assets38.7%
Cash & investments$195.59M
Total debt$21.73M
Net cash (debt)$173.86M
Free cash flow / sales13.4%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Fertility benefits services revenue$223.37M 65.5%
  • Pharmacy benefits services revenue$117.88M 34.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $341.25M $350.51M $328.50M $1.29B $318.40M
Total Operating Revenue $341.25M $350.51M $328.50M $1.29B $318.40M
Cost of Revenue $257.51M $261.21M $245.43M $984.18M $241.52M
Gross Profit $83.74M $89.30M $83.07M $304.48M $76.88M
Operating Expense $48.56M $49.30M $47.69M $219.21M $61.66M
Selling and Admin Expenses $48.56M $49.30M $47.69M $219.21M $61.66M
-Selling & Marketing Expense $18.06M $18.07M $16.88M $72.11M $17.99M
-General & Admin Expense $30.50M $31.22M $30.81M $147.09M $43.67M
Operating Profit $35.18M $40.00M $35.38M $85.28M $15.22M
Net Non-Operating Interest Income (Expense) $1.23M $1.13M $1.50M $10.16M $2.63M
Non-Operating Interest Income $1.23M $1.13M $1.50M $10.16M $2.63M
Pretax Profit $36.42M $41.14M $36.88M $95.43M $17.85M
Tax $10.16M $13.09M $12.65M $36.91M $5.37M
Net Profit $26.25M $28.05M $24.23M $58.52M $12.49M
Profit from Continuing Operations $26.25M $28.05M $24.23M $58.52M $12.49M
Net Income to Parent Company $26.25M $28.05M $24.23M $58.52M $12.49M
Net Income to Common Stockholders $26.25M $28.05M $24.23M $58.52M $12.49M
Basic EPS $0.34 $0.36 $0.30 $0.68 $0.15
Diluted EPS $0.32 $0.34 $0.29 $0.65 $0.14

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $675.79M $715.84M $698.34M $742.44M $742.44M
Total Current Assets $464.40M $513.02M $501.55M $551.78M $551.78M
Cash and Cash Equivalents & Short-Term Investments $195.59M $236.93M $225.11M $310.10M $310.10M
-Cash and Cash Equivalents $116.82M $152.63M $131.61M $112.24M $112.24M
-Short Term Investments $78.77M $84.29M $93.50M $197.86M $197.86M
Receivables $249.18M $257.48M $263.61M $220.29M $220.29M
-Accounts Receivable $249.18M $257.48M $263.61M $220.29M $220.29M
Other Current Assets $19.63M $18.62M $12.83M $21.39M $21.39M
Total Non-Current Assets $211.39M $202.82M $196.79M $190.66M $190.66M
Net PPE $73.12M $65.57M $59.98M $54.92M $54.92M
-Gross PPE $73.12M $65.57M $59.98M $67.26M $67.26M
Goodwill and Other Intangible Assets $25.36M $25.60M $25.85M $26.19M $26.19M
-Goodwill $19.83M $19.85M $19.88M $19.98M $19.98M
-Other Intangible Assets $5.53M $5.75M $5.97M $6.22M $6.22M
Non-Current Deferred Assets $93.08M $93.08M $93.08M $93.01M $93.01M
Other Non-Current Assets $19.83M $18.57M $17.87M $16.54M $16.54M
Total Liabilities $261.77M $262.58M $258.99M $226.39M $226.39M
Total Current Liabilities $240.04M $240.08M $235.74M $202.39M $202.39M
Payables $148.00M $152.05M $157.83M $154.03M $154.03M
-Accounts Payable $148.00M $152.05M $157.83M $124.07M $124.07M
Current Accrued Expenses $92.04M $88.03M $77.92M $21.16M $21.16M
Total Non-Current Liabilities $21.73M $22.50M $23.25M $24.00M $24.00M
Long Term Debt and Capital Lease Obligation $21.73M $22.50M $23.25M $24.00M $24.00M
-Long Term Capital Lease Obligation $21.73M $22.50M $23.25M $24.00M $24.00M
Total Equity $414.03M $453.26M $439.34M $516.04M $516.04M
Stockholders' Equity $414.03M $453.26M $439.34M $516.04M $516.04M
Capital Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
-Common Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
Additional Paid-In Capital $753.52M $735.42M $717.76M $700.79M $700.79M
Retained Earnings $281.36M $255.11M $227.06M $202.83M $202.83M
Less: Treasury Stock -$621.04M -$537.53M -$505.76M -$388.08M -$388.08M
Gains/Losses Not Affecting Retained Earnings $173,000.00 $245,000.00 $277,000.00 $498,000.00 $498,000.00
-Accumulated Depreciation – – – -$12.34M -$12.34M
-Other Payable – – – $29.95M $29.95M
Short-Term Debt and Capital Lease Obligation – – – $3.73M $3.73M
-Current Capital Lease Obligation – – – $3.73M $3.73M
Other Current Liabilities – – – $1.91M $1.91M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $56.61M $50.43M $45.95M $210.19M $54.20M
Net cash flow from continuing operations $56.61M $50.43M $45.95M $210.19M $54.20M
Net Income from Continuing Operations $26.25M $28.05M $24.23M $58.52M $12.49M
Gain/Loss from Continuing Operations $131,000.00 $528,000.00 $52,000.00 $79,000.00 $0.00
Depreciation & Depletion & Amortization $2.15M $1.62M $1.48M $4.95M $1.37M
Deferred Tax $9,000.00 $10,000.00 $10,000.00 -$8.12M -$8.15M
Other Non-Cash Items $154,000.00 $158,000.00 $279,000.00 $434,000.00 $155,000.00
Change in Working Capital $2.96M -$5.58M -$5.41M $2.80M $8.80M
-Change in Receivables $5.23M $385,000.00 -$47.77M -$5.12M $27.04M
-Change in Prepaid Assets -$997,000.00 -$5.79M $9.60M -$11.95M $2.91M
-Change in Payables and Accrued Expense -$123,000.00 $657,000.00 $35.17M $29.17M -$11.81M
-Change In Other Working Capital -$1.15M -$829,000.00 -$2.41M -$9.31M -$9.35M
Net cash flow from investing -$5.02M $3.55M $96.59M -$159.01M $8.26M
Net Cash Flow from Continuing Investing Activities -$5.02M $3.55M $96.59M -$159.01M $8.26M
Net PPE Purchase and Sale -$9.37M -$6.22M -$6.35M -$18.41M -$5.61M
Net Business Purchase and Sale $0.00 $0.00 $0.00 -$9.34M $0.00
Net Investment Purchase and Sale $4.35M $9.77M $102.94M -$131.26M $13.87M
Financing Cash Flow -$87.40M -$32.89M -$123.11M -$99.36M -$88.26M
Net Cash Flow from Continuing Financing Activities -$87.40M -$32.89M -$123.11M -$99.36M -$88.26M
Net Common Stock Issuance -$82.78M -$30.02M -$118.61M -$81.66M -$81.66M
Proceeds from Stock Option Exercised $392,000.00 $360,000.00 $337,000.00 $1.23M $426,000.00
Net Other Financing Charges -$5.02M -$3.23M -$4.84M -$18.94M -$7.03M
Ending Cash Balance $118.80M $154.60M $133.57M $114.19M $114.19M
Net Change in Cash -$35.81M $21.08M $19.43M -$48.18M -$25.80M
Beginning Cash Balance $154.60M $133.57M $114.19M $162.31M $139.98M
Effect of Exchange Rate Changes $9,000.00 -$51,000.00 -$51,000.00 $62,000.00 $13,000.00
Free Cash Flow $47.24M $44.21M $39.60M $191.78M $48.59M

Discussion

No comments yet — be the first to weigh in on PGNY.

Sign in to join the discussion.

Scroll to Top